Insitro, Inc.
Biotechnology
Insitro is a pioneering biotechnology company revolutionizing drug discovery through machine learning and data integration. By combining in vitro cellular data with human clinical data, Insitro develops innovative therapeutic programs in metabolism, oncology, and neuroscience, aiming to accelerate the creation of transformative medicines for patients.
Founded: 2018
Daphne Koller Founder and CEO |
Ajamete Kaykas Chief eXploration Officer and Head of Neuroscience |
Jevan Soo Lenox Chief People Officer |
Martha Rook Chief Technical Operations Officer |
Mary Rozenman CFO/CBO |
Philip Tagari Chief Scientific Officer |